THE DAILY

Liraglutide

Grade A — Excellent

FDA-approved GLP-1 for weight loss and blood sugar control with daily dosing.

Also known as: Saxenda, Victoza

Weight Loss
Metabolic Health
GLP-1
Appetite Control
Blood Sugar

Overview

Liraglutide is a GLP-1 receptor agonist that works similarly to Semaglutide but requires daily injections instead of weekly. It helps control appetite, slows digestion, and improves blood sugar regulation. Originally developed for diabetes (Victoza), a higher dose version (Saxenda) was approved specifically for weight management. It's a proven option for those who prefer more frequent, smaller doses.

Dosing Guide

Dosage

0.6mg to 3mg daily (gradual increase)

Schedule

daily

Cycle

Continuous use with medical supervision

Pro Tip

Start at 0.6mg and increase by 0.6mg weekly to minimize nausea

Safety Profile

A

FDA Approved

Excellent

FDA-approved with extensive clinical trial data. Well-established safety profile.

Requires gradual dose escalation. Not for those with history of thyroid cancer or MEN2.

Possible Side Effects

Nausea
Diarrhea
Constipation
Injection site reactions

Who Is This For

People seeking FDA-approved weight loss medication
Type 2 diabetics needing blood sugar control
Those who prefer daily dosing over weekly
Individuals starting GLP-1 therapy

Related Peptides

Adipotide

C

THE FAT BURNER

Targets and destroys fat cells by cutting off their blood supply.

Survodutide

B

THE DUAL ACTION

Next-generation dual GLP-1/glucagon agonist for enhanced weight loss and metabolic benefits.

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App